REGENXBIO, Inc. (RGNX)
7.43
+0.01
(+0.13%)
USD |
NASDAQ |
Oct 02, 16:00
7.54
+0.11
(+1.48%)
After-Hours: 20:00
REGENXBIO Price to Book Value : 5.608 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 5.608 |
| October 01, 2026 | 5.600 |
| September 30, 2026 | 5.683 |
| September 29, 2026 | 5.623 |
| September 28, 2026 | 5.638 |
| September 25, 2026 | 5.585 |
| September 24, 2026 | 5.464 |
| September 23, 2026 | 5.661 |
| September 22, 2026 | 6.151 |
| September 21, 2026 | 5.947 |
| September 18, 2026 | 6.061 |
| September 17, 2026 | 6.200 |
| September 16, 2026 | 6.023 |
| September 15, 2026 | 5.996 |
| September 14, 2026 | 6.559 |
| September 11, 2026 | 6.438 |
| September 10, 2026 | 6.461 |
| September 09, 2026 | 6.589 |
| September 08, 2026 | 6.612 |
| September 04, 2026 | 6.747 |
| September 03, 2026 | 6.944 |
| September 02, 2026 | 7.246 |
| September 01, 2026 | 7.034 |
| August 31, 2026 | 7.17 |
| August 28, 2026 | 7.291 |
| Date | Value |
|---|---|
| August 27, 2026 | 7.072 |
| August 26, 2026 | 7.080 |
| August 25, 2026 | 6.725 |
| August 24, 2026 | 6.079 |
| August 21, 2026 | 8.091 |
| August 20, 2026 | 8.347 |
| August 19, 2026 | 9.072 |
| August 18, 2026 | 8.355 |
| August 17, 2026 | 8.551 |
| August 14, 2026 | 8.125 |
| August 13, 2026 | 8.046 |
| August 12, 2026 | 8.234 |
| August 11, 2026 | 8.038 |
| August 10, 2026 | 7.864 |
| August 07, 2026 | 8.091 |
| August 06, 2026 | 8.514 |
| August 05, 2026 | 7.925 |
| August 04, 2026 | 7.774 |
| August 03, 2026 | 7.517 |
| July 31, 2026 | 7.313 |
| July 30, 2026 | 7.638 |
| July 29, 2026 | 7.261 |
| July 28, 2026 | 7.246 |
| July 27, 2026 | 7.328 |
| July 24, 2026 | 7.344 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| United Therapeutics Corp. | 3.612 |
| Ardelyx, Inc. | 5.584 |
| Biomea Fusion, Inc. | 7.585 |
| RenovoRx, Inc. | 7.940 |
Price to Book Value Related Metrics
| PS Ratio | 2.224 |
| PEG Ratio | -0.2121 |
| Price | 7.43 |
| Earnings Yield | -50.94% |
| Market Cap | 402.44M |
| PEGY Ratio | -0.2121 |